Filing search / Articles / eFFECTOR Therapeutics, Inc.

8-K

EX-3.1

EFTR eFFECTOR Therapeutics, Inc.

14 Jun 24

Amendments to Articles of Incorporation or Bylaws

4:01pm

8-K/A

EX-3.1

EFTR eFFECTOR Therapeutics, Inc.

9 May 24

Entry into a Material Definitive Agreement

4:34pm

8-K

EX-3.1

EFTR eFFECTOR Therapeutics, Inc.

9 May 24

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

4:06pm

8-K

EX-3.1

EFTR eFFECTOR Therapeutics, Inc.

10 Jan 24

Material Modifications to Rights of Security Holders

8:01am

8-K

EX-3.1

EFTR eFFECTOR Therapeutics, Inc.

23 Jun 23

Amendments to Articles of Incorporation or Bylaws

4:01pm

8-K/A

EX-3.1

qlssghg1yfbzkxwgvlaa

31 Aug 21

Changes in Registrant's Certifying Accountant

4:38pm

8-K/A

EX-3.2

09z1gm5ua797ea

31 Aug 21

Changes in Registrant's Certifying Accountant

4:38pm

8-K

EX-3.1

poq000h55

31 Aug 21

Entry into a Material Definitive Agreement

4:10pm

8-K

EX-3.2

tzel 9efjxt0ra

31 Aug 21

Entry into a Material Definitive Agreement

4:10pm

8-K

EX-3.1

jh6cwp

13 Jan 21

Locust Walk Acquisition Corp. Announces Pricing of Upsized $153,000,000 Initial Public Offering

4:30pm

S-1

EX-3.2

856b9 7src9vi

18 Dec 20

IPO registration

4:33pm

S-1

EX-3.2

hiu94yt

18 Dec 20

IPO registration

4:33pm

S-1

EX-3.1

pn5ltjt8r

18 Dec 20

IPO registration

4:33pm

S-1

EX-3.1

08cvh7z

18 Dec 20

IPO registration

4:33pm

DRS

EX-3

rzfos

4 Nov 20

Draft registration statement

12:00am

DRS

EX-3

5q17r qubj5a

4 Nov 20

Draft registration statement

12:00am